Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:1309-1314

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heringer-Walther, S.
Right arrow Articles by Campagnole-Santos, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heringer-Walther, S.
Right arrow Articles by Campagnole-Santos, M. J.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2001;37:1309.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Baroreflex Improvement in SHR After ACE Inhibition Involves Angiotensin-(1-7)

Silvia Heringer-Walther; Érica N. Batista; Thomas Walther; Mahesh C. Khosla; Robson A. S. Santos; Maria J. Campagnole-Santos

From the Department of Physiology and Biophysics, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte (S.H.-W., E.N.B., R.A.S.S., M.J.C.-S.), Brazil; the Department of Cardiology and Pneumology, University Hospital Benjamin Franklin, Free University of Berlin (S.H.-W., T.W.), Berlin, Germany; and the Department of Neurosciences, Cleveland Clinic Foundation (M.C.K.), Cleveland, Ohio.

Correspondence to Maria Jose Campagnole-Santos, PhD, Departamento de Fisiologia e Biofísica, Av. Antonio Carlos, 6627-ICB-UFMG, 31270-901 Belo Horizonte, MG, Brazil. E-mail mjcs{at}icb.ufmg.br

Abstract—ACE inhibitors are extensively used in the treatment of hypertension mainly because of their efficiency in reducing blood pressure levels and decreasing vascular and cardiac hypertrophy. In addition, ACE inhibitors improve baroreceptor reflex control. Chronic inhibition of ACE produces (in addition to decreased angiotensin II levels) a severe increase in angiotensin-(1-7) [Ang-(1-7)] levels in several species. We have previously shown that Ang-(1-7) produces a facilitation of the baroreflex control of heart rate. In this study, we evaluated the participation of endogenous Ang-(1-7) in the improvement of baroreflex sensitivity in spontaneously hypertensive rats after central infusion of ramiprilat, an ACE inhibitor. Reflex changes in heart rate were elicited, in conscious rats, by bolus injections of phenylephrine (baroreflex bradycardia) before and after intracerebroventricular infusion of (1) saline (8 µL/h), 4 hours (n=5); (2) ramiprilat (14 µg/h), 4 hours (n=6); (3) ramiprilat for 2 hours, followed by ramiprilat combined with A-779 (4 µg/h), a selective Ang-(1-7) antagonist, for an additional 2 hours (n=6); and (4) A-779 for 2 hours, followed by A-779 combined with ramiprilat for an additional 2 hours (n=5). Intracerebroventricular infusion of ramiprilat produced an important increase ({approx}40%) in baroreflex sensitivity (evaluated as the ratio between changes in heart rate and changes in mean arterial pressure) that was completely reversed by A-779. Furthermore, intracerebroventricular infusion of A-779 prevented the improvement of the baroreflex sensitivity produced by ramiprilat. Intracerebroventricular infusion of saline or A-779 alone did not significantly alter the baroreflex sensitivity. These results suggest that endogenous Ang-(1-7) is involved in the improvement of baroreflex sensitivity observed in spontaneously hypertensive rats during central ACE inhibition.


Key Words: angiotensin-(1-7) • baroreceptors • angiotensin-converting enzyme inhibitors • renin-angiotensin system • rats, inbred SHR • A-779




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. K. Becker, G. M. Etelvino, T. Walther, R. A. S. Santos, and M. J. Campagnole-Santos
Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1416 - H1424.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Q. Gomes da Silva, R. A. Sousa dos Santos, and M. A. Peliky Fontes
Blockade of Endogenous Angiotensin-(1-7) in the Hypothalamic Paraventricular Nucleus Reduces Renal Sympathetic Tone
Hypertension, August 1, 2005; 46(2): 341 - 348.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q. Fu, R. Zhang, S. Witkowski, A. Arbab-Zadeh, A. Prasad, K. Okazaki, and B. D. Levine
Persistent Sympathetic Activation During Chronic Antihypertensive Therapy: A Potential Mechanism for Long Term Morbidity?
Hypertension, April 1, 2005; 45(4): 513 - 521.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. A. S. Santos, A. C. S. e Silva, C. Maric, D. M. R. Silva, R. P. Machado, I. de Buhr, S. Heringer-Walther, S. V. B. Pinheiro, M. T. Lopes, M. Bader, et al.
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
PNAS, July 8, 2003; 100(14): 8258 - 8263.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. A.S. Santos, A. S. Haibara, M. J. Campagnole-Santos, A. C. Simoes e Silva, R. D. Paula, S. V.B. Pinheiro, M. de Fatima Leite, V. S. Lemos, D. M.R. Silva, M. T. Guerra, et al.
Characterization of a New Selective Antagonist for Angiotensin-(1-7), D-Pro7-Angiotensin-(1-7)
Hypertension, March 1, 2003; 41(3): 737 - 743.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. N. G. Braga, M. Da Silva Lemos, J. R. Da Silva, W. R. P. Fontes, and R. Augusto Souza Dos Santos
Effects of angiotensins on day-night fluctuations and stress-induced changes in blood pressure
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1663 - R1671.
[Abstract] [Full Text] [PDF]